Type 2 diabetes data In a separate Phase 2 trial, retatrutide was tested in adults with type 2 diabetes
(doi:10.1007/s00125-010-1937-z) report that metformin acutely increases plasma levels of glucagon-like peptide 1 (GLP-1) in mice
They lose more weight, have more significant improvements in weight-related co-morbidities, and the results are more durable
There are currently no GLP-1 medications that can be absorbed through the skin, says C
Inflammation markers when clinically useful
Additionally, berberine and other patch ingredients can cause side effects such as: Upset stomach Diarrhea Constipation Excess gas The severity and duration of these side effects are uncertain, unlike GLP-1 injections, whose side effects are well-documented and tend to stabilize over time